How to Decide Long-Acting Insulin Dose in Patients with Type 2 Diabetes
Start basal insulin at 10 units per day OR 0.1-0.2 units/kg/day if A1C <8%, and 0.2-0.3 units/kg/day if A1C ≥8%. 1, 2
Initial Dosing Algorithm
The starting dose depends primarily on baseline A1C:
- A1C <8% (<64 mmol/mol): Begin with 0.1-0.2 units/kg/day 2
- A1C ≥8% (≥64 mmol/mol): Begin with 0.2-0.3 units/kg/day 2
- Alternative fixed-dose approach: Start with 10 units per day regardless of weight 1, 3
For patients with severe hyperglycemia (A1C >10% or blood glucose ≥300 mg/dL) with symptoms, insulin should be initiated promptly at the higher end of dosing (0.2-0.3 units/kg/day) 1, 2.
Titration Strategy
Titrate every 2-3 days based on fasting blood glucose, with the goal of reaching fasting plasma glucose <110 mg/dL without hypoglycemia 2. The most recent AACE 2023 guidelines provide a clear adjustable regimen 2:
Evidence-Based Titration Protocol:
- FBG >180 mg/dL: Increase by 20% of total daily dose
- FBG 140-180 mg/dL: Increase by 10% of total daily dose
- FBG 110-139 mg/dL: Increase by 1 unit
- FBG <70 mg/dL: Decrease by 10-20%
- FBG <40 mg/dL: Decrease by 20-40%
Alternatively, a simpler fixed regimen increases the dose by 2 units every 2-3 days 1, 2. The ADA 2023 guidelines recommend increasing by 2 units every 3 days or by 10-15% (2-4 units) once or twice weekly 1, 3.
Important Caveats
Longer-acting basal insulins require slower titration. Glargine U-300 and degludec U-100/U-200 have longer times to steady state and should be titrated every ≥3 days rather than every 2-3 days 2. This is a critical safety consideration often overlooked.
Watch for overbasalization. If basal insulin doses exceed 0.5 units/kg/day and A1C remains above target, this signals inadequate basal insulin alone 1, 2. At this point, adding prandial insulin or a GLP-1 receptor agonist is more appropriate than continuing to increase basal insulin 1.
Special Populations
For elderly or frail patients with hypoglycemia risk (acute kidney injury, cognitive impairment), reduce the starting dose to 0.15 units/kg/day 2. Set more liberal fasting glucose targets of 90-150 mg/dL rather than <110 mg/dL 4.
For hospitalized patients with mild hyperglycemia (<200 mg/dL), consider low-dose basal insulin (0.1 units/kg/day) with correction doses 5. Those with moderate hyperglycemia (201-300 mg/dL) should start at 0.2-0.3 units/kg/day 5.
Insulin Selection Considerations
Analog insulins (glargine, detemir, degludec) are preferred over NPH to reduce hypoglycemia risk 2. However, NPH remains a more affordable option when cost is prohibitive 1, 3. The evidence shows glargine U-300 and degludec U-100 lead to fewer hypoglycemic events than older formulations without compromising glycemic control 6.
Key Pitfalls to Avoid
- Don't delay titration. Adjust doses every 2-3 days, not weekly or monthly, to avoid therapeutic inertia 1, 2
- Don't ignore hypoglycemia. Always determine the cause; if unclear, reduce dose by 10-20% 1, 2
- Don't continue escalating basal insulin indefinitely. Doses >0.5 units/kg/day signal need for treatment intensification, not further basal increases 1, 2
- Don't forget to discontinue sulfonylureas when starting basal insulin to reduce hypoglycemia risk 2